News In groundbreaking research, Tel Aviv U team records plants ‘talking’ for first time | The Times of Israel
News U.S. FDA Approves Over-the-Counter Designation for Emergent BioSolutions’ NARCAN® Nasal Spray, a Historic Milestone for the Opioid Overdose Emergency Treatment
News Gaithersburg’s Salubris Biotherapeutics Announces $35 Million Financing to Advance Development Activities and Provides Pipeline Updates
News Exploring the Reversal of Cancer Resistance: A BioTalk Podcast Discussion with Vishal Doshi of AUM Biosciences
News MacroGenics Earns $15 Million Milestone Following U.S. FDA Approval of ZYNYZ™ (retifanlimab-dlwr)